NPI: 1841308020 · BIRMINGHAM, AL 35235 · 282N00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,445 | $467K |
| 2019 | 12,480 | $459K |
| 2020 | 7,527 | $271K |
| 2021 | 8,682 | $317K |
| 2022 | 9,858 | $497K |
| 2023 | 14,058 | $777K |
| 2024 | 4,679 | $254K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | 4,472 | 4,008 | $1.20M | |
| 99284 | 16,621 | 15,152 | $1.08M | |
| 99283 | 9,276 | 8,543 | $362K | |
| 80053 | 11,324 | 10,288 | $109K | |
| 85025 | 13,376 | 12,119 | $105K | |
| 87636 | 951 | 909 | $93K | |
| 87502 | 894 | 832 | $38K | |
| 81001 | 2,736 | 2,531 | $9K | |
| 71045 | 1,082 | 1,014 | $7K | |
| 93005 | 516 | 479 | $6K | |
| U0002 | Covid-19 lab test non-cdc | 427 | 411 | $5K |
| J1885 | Ketorolac tromethamine inj | 2,991 | 2,696 | $4K |
| 83690 | 646 | 606 | $3K | |
| 87651 | 128 | 126 | $3K | |
| 71046 | 286 | 267 | $3K | |
| 81025 | 704 | 664 | $2K | |
| 80061 | 126 | 125 | $2K | |
| J0696 | Ceftriaxone sodium injection | 945 | 855 | $2K |
| 99282 | 29 | 27 | $1K | |
| J1100 | Dexamethasone sodium phos | 1,150 | 1,018 | $1K |
| 87070 | 92 | 86 | $956.69 | |
| 84484 | 113 | 104 | $924.73 | |
| 80048 | 130 | 70 | $863.10 | |
| 87086 | 70 | 65 | $790.85 | |
| 85610 | 196 | 177 | $686.30 | |
| 83036 | 35 | 28 | $353.50 | |
| 85730 | 181 | 163 | $346.91 | |
| J2405 | Ondansetron hcl injection | 568 | 524 | $144.78 |
| 84443 | 15 | 13 | $130.13 | |
| 84134 | 19 | 17 | $123.50 | |
| Q9967 | Locm 300-399mg/ml iodine,1ml | 36 | 24 | $72.12 |
| 82947 | 12 | 12 | $46.50 | |
| 81003 | 13 | 13 | $29.61 | |
| J7030 | Normal saline solution infus | 639 | 593 | $2.69 |
| A9270 | Non-covered item or service | 236 | 213 | $0.00 |
| 36415 | 464 | 352 | $0.00 | |
| 96374 | 104 | 88 | $0.00 | |
| 96372 | 113 | 92 | $0.00 | |
| 96375 | 13 | 12 | $0.00 |